Approval · Notice of Compliance 7211 · 2005
TARCEVA: Notice of Compliance 7211
Issued July 7, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7211
- Date
- July 7, 2005
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Epidermal growth factor tyrosine kinase inhibitor